Work

Abstract 4547: TRO-02, a conditionally activated EGFR-targeting ADC incorporating TROCADTM and TROSIGTM platforms, shows enhanced tumor selectivity and potent efficacy

Year: 2026
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148816424
Cites:
Cited by:
Related to: